A dwindling COVID-19 vaccine market is not stopping Arcturus Therapeutics from pressing ahead with its own mRNA candidate, as the biotech touts new early data indicating its shot lights up the immune ...
SAN ANTONIO — We're approaching three years since COVID-19 reared its ugly head to the world, and we're getting used to living with it. But COVID numbers are once again on the way up. We are in the ...
KING OF PRUSSIA, Pa. & SAN DIEGO--(BUSINESS WIRE)-- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the results of a follow-up analysis ...
SAN ANTONIO — People battling long COVID have suffered for months and years, often with debilitating symptoms. In this Healthy SA, we learn how experts are finally defining the condition after four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback